Serum elaidic acid concentration and risk of dementia
The Hisayama Study
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received November 8, 2018
- Accepted in final form June 28, 2019
- First Published October 23, 2019.
Article Versions
- Previous version (October 23, 2019 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Takanori Honda, PhD,
- Tomoyuki Ohara, MD, PhD,
- Masakazu Shinohara, MD, PhD,
- Jun Hata, MD, PhD,
- Ryuji Toh, MD, PhD,
- Daigo Yoshida, PhD,
- Mao Shibata, MD, PhD,
- Tatsuro Ishida, MD, PhD,
- Yoichiro Hirakawa, MD, PhD,
- Yasuhiro Irino, PhD,
- Satoko Sakata, MD, PhD,
- Kazuhiro Uchida, PhD,
- Takanari Kitazono, MD, PhD,
- Shigenobu Kanba, MD, PhD,
- Ken-Ichi Hirata, MD, PhD and
- Toshiharu Ninomiya, MD, PhD
- Takanori Honda, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tomoyuki Ohara, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Masakazu Shinohara, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jun Hata, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ryuji Toh, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Sysmex Corporation
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Daigo Yoshida, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mao Shibata, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tatsuro Ishida, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yoichiro Hirakawa, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Yasuhiro Irino, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Sysmex Corporation
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Satoko Sakata, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Kazuhiro Uchida, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Takanari Kitazono, MD, PhD,
NONE
NONE
Daiichi Sankyo Co., Ltd. Bayer Yakuhin, Ltd.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Daiichi Sankyo Co., Ltd. Takeda Pharmaceutical Co., Ltd. Astellas Pharma Inc. Chugai Pharaceutical Co., Ltd. MSD K.K. Nippon Behringer Ingelheim Co., Ltd.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Shigenobu Kanba, MD, PhD,
Astellas
NONE
received honoraria for lectures from Eli Lilly, GlaxoSmithKline, Pfizer Inc, Asahi- kasei, Meiji Seika Pharma, Taisho Toyama, Janssen, Eisai, Astellas, Otsuka, Shionogi, Dainippon Sumitomo, Kyowa Hakko Kirin, Yoshitomiyakuhin, MSD, and Wyeth
Molecular Psychiatry, Journal of Neuroscience and Psychiatry, Asian Journal of Psychiatry, Asia Pacific Journal of Psychiatry
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Pfizer Inc., GlaxoSmithKline, Astellas, Janssen, Yoshitomiyakuhin, Eli Lilly, Otsuka, Dainippon Sumitomo, Meiji Seika Pharma, Kyowa Hakko Kirin, Shionogi, Ono Pharma
Grant from Japanese Ministry of Education and of Health
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ken-Ichi Hirata, MD, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Toshiharu Ninomiya, MD, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Epidemiology and Public Health (T.H., T.O., J.H., D.Y., M.Shibata, Y.H., S.S., T.N.), Neuropsychiatry (T.O., S.K.), Medicine and Clinical Science (J.H., Y.H., S.S., T.K.), and Psychosomatic Medicine (M.Shibata), and Center for Cohort Studies (J.H., M.Shibata, S.S., T.K., T.N.), Graduate School of Medical Sciences, Kyushu University, Fukuoka; Divisions of Epidemiology (M.Shinohara), Evidence-Based Laboratory Medicine (R.T., Y.I.), and Cardiovascular Medicine (T.I., K.-I.H.), and Integrated Center for Mass Spectrometry (M.Shinohara., Y.I.), Kobe University Graduate School of Medicine, Hyogo; and Department of Health Promotion (K.U.), School of Health and Nutrition Sciences, Nakamura-Gakuen University, Fukuoka, Japan.
- Correspondence
Dr. Ninomiya nino{at}eph.med.kyushu-u.ac.jp
Article usage
Cited By...
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.